Complex Profiles of Cerebrovascular Disease Pathologies in the Aging Brain and Their Relationship With Cognitive

Melissa Lamar1,2, Sue Leurgans1,3, Alifiya Kapasi1,4

  • 1Rush Alzheimer's Disease Center (M.L., S.L., A.K., L.L.B., P.A.B., D.A.B., K.A., J.A.S.), Rush University Medical Center, Chicago, IL.

Stroke
|October 4, 2021
PubMed

Insights

Mixed cerebrovascular disease (CVD) profiles are more common and linked to faster cognitive decline than single CVD. Specific combinations of vessel disease and tissue injury differentially impact cognitive domains in dementia.

Area of Science:

  • Neurology
  • Pathology
  • Gerontology

Background:

  • Cerebrovascular disease (CVD) encompasses vessel diseases and tissue injury, contributing to Alzheimer's and other dementias.
  • The interplay of various CVD combinations and their cognitive impact remains largely uncharacterized.

Purpose of the Study:

  • To investigate the frequencies of 32 cerebrovascular disease (CVD) combinations.
  • To determine the associations between these CVD combinations and cognitive decline.

Main Methods:

  • Utilized autopsy data from 1474 decedents from Rush Alzheimer's Disease Center studies.
  • Employed mixed-effect models to analyze 32 CVD combinations and their relationship with cognitive decline, adjusting for covariates.

Main Results:

  • 80% of decedents had CVD; 63% exhibited mixed CVD profiles, compared to 37% with single CVD.
  • Mixed CVD profiles were associated with significantly faster cognitive decline across all domains compared to no CVD.
  • Specific mixed CVD combinations, particularly those with atherosclerosis and arteriolosclerosis, showed distinct associations with cognitive domains.

Conclusions:

  • Mixed cerebrovascular disease (CVD) is more prevalent than single CVD and significantly associated with accelerated cognitive decline.
  • Distinct combinations of CVD pathologies contribute heterogeneously to cognitive decline, impacting specific cognitive domains.
Abstract

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
389
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
762
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
43
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
329
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
245
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
25